MarkNtel Advisors, a leading market research and consulting firm, has announced the release of its latest study titled Plasma Fractionation Market Research Report Forecast (2025-2030). This report provides a detailed assessment of the Plasma Fractionation Market, covering its evolving dynamics, emerging trends, key growth drivers, major challenges, and competitive landscape.

Designed to guide investors, stakeholders, and business leaders, the research aims to deliver valuable insights for strategic planning, risk assessment, and investment decision-making in the years ahead.

Market Timeline Overview

  • Historical Years: 2020-23
  • Base Years: 2024
  • Forecast year - 2025-2030

This helps businesses identify emerging opportunities, assess market risks, and develop data-driven strategies for long-term success.

In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecast for years 2026 to 2032, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report.

Download a FREE PDF Sample of the Report: https://www.marknteladvisors.com/query/request-sample/plasma-fractionation-market.html  (Discover the market potential, platform-specific insights, and key industry trends.)

Plasma Fractionation Market Outlook

According to the report, The Global Plasma Fractionation Market size was valued at around USD 31.18 billion in 2024 and is projected to reach USD 42.39 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 5.51% during the forecast period, i.e., 2025-30. The demand for plasma-derived therapy has been increasing worldwide, owing to the prevalence of rare disorders in the global population. In 2023, according to the Rare Disease Day Organization, around 300 million people worldwide are living with a rare disorder.

The growth of the market is projected to be driven primarily by massive investments by the US government in expansions of industries like construction, transportation, corporate, & hospitality, among others. Consequently, the demand for facility management services is on an unprecedented rise to improve the overall operational efficiency & productivity of businesses with increased cost-effectiveness.

The report also examines consumer preferences, regulatory impacts, and investment trends that will shape the market’s trajectory over the next decade.

Plasma Fractionation Market Drivers:

Escalating Geriatric Population Driving the Demand for Plasma-derived Therapies – Globally, the surging geriatric population has resulted in a substantial boost in the incidences of diseases like immunodeficiency, neurological disorders, etc., which require plasma-derived therapies for treatment. The increment in the geriatric population has been attributed to the increasing life expectancy of the elderly population in various countries like China, Japan, etc., as a result of their improved healthcare infrastructure. Consequently, as the number of geriatric patients has been increasing, there has been an enhanced demand for plasma-derived therapeutic products, presenting a strong market situation for plasma fractionation manufacturers, particularly immunoglobulins and coagulation factors during historical years.

View Full Report (All Data, In One Place): https://www.marknteladvisors.com/research-library/plasma-fractionation-market.html (Explore in-depth analyses, technological trends, and investment patterns.)

Plasma Fractionation Market Trends:

Expansion of Plasma Fractionation Plants Gaining Traction – The growing positive outcomes of plasma-derived drugs for chronic, autoimmune, and other diseases have raised the demand for plasma fractionation products in the market. The booming demand for plasma fractionation products has prompted global players in the Plasma Fractionation Market, such as Takeda Pharmaceuticals and Grifols, to embark on a trend of establishing new plasma fractionation manufacturing facilities worldwide. For instance:

  • In 2022, Takeda announced an investment of nearly USD 300 million to construct a new production facility and a warehouse for plasma-derived therapies in Belgium.

Plasma Fractionation Market Segmentation

The study categorizes the Plasma Fractionation Market into various segments and sub-segments, each analyzed for its size, growth potential, and contribution to the overall industry.

By Product

  • Immunoglobulin
    • Intravenous Immunoglobulin
    • Subcutaneous Immunoglobulin
    • Other Disease Specific Immunoglobulins (Hepatitis B Immunoglobulin, Tetanus Immunoglobulin, etc.)
  • Coagulation Factors
    • Factor VIII
    • Factor IX
    • Von Willebrand Factor (vWF)
    • Prothrombin Complex Concentrates
    • Fibrinogen Concentrates
    • Factor XIII
    • Others (Factor VIIa, Factor XI, etc.)
  • Albumin
  • Protease Inhibitor
  • Others (Plasminogen, Antithrombin III, etc.)

By Application

  • Neurology
  • Immunology
  • Hematology
  • Critical Care
  • Pulmonology
  • Rheumatology
  • Others (Oncology, Pediatrics, etc.)

By End User

  • Hospitals
  • Specialty Clinics
  • Research Facilities

Geographical Analysis

The report presents detailed insights into the market’s geographical expansion, highlighting key trends and opportunities across the following geographies:

By Region

  • North America
  • South America
  • Europe
  • The Middle East & Africa
  • Asia-Pacific

Talk to Our Industry Analyst: https://www.marknteladvisors.com/query/talk-to-our-consultant/plasma-fractionation-market.html Get personalized insights into company strategies and regional market dynamics.)

Leading Companies in Plasma Fractionation Market Worldwide: Players, Analysis & Future Outlook

Compass Group, Sodexo, EMCOR, Cushman & Wakefield, Trane, CBRE, Jones Lang LaSalle Incorporated (JLL), G4S PLC, ISS, Ecolab, and others are the top companies in the Plasma Fractionation Market.

Key Highlights of the Report

  • Comprehensive Market Overview: In-depth analysis of market size, share, and forecasts from 2025 to 2030.
  • Growth Drivers & Challenges: Clear insights into factors feeling or restraining market expansion.
  • Investment & Regulatory Insights: Evaluation of key policies, funding trends, and collaborations influencing industry performance.
  • Competitive Landscape: Detailed profiles of leading companies, including product portfolios, business strategies, financials, and recent developments such as mergers & acquisitions.

Analytical Tools: Application of SWOT Analysis, PESTEL Analysis, and Porter’s Five Forces Model to assess competition and external influences

Browse through our flexible pricing plans and choose the package that best fits your business needs whether you require a single-user license, corporate access, or customized insights. Once you select the plan that suits your requirements, you can purchase and instantly access the full report online – https://www.marknteladvisors.com/pricing/plasma-fractionation-market.html 

Frequently Asked Questions (FAQ)

1. What is the projected growth rate of the Plasma Fractionation Market?
2. What are the major factors driving this market’s growth?
3. Which regions are expected to lead the Plasma Fractionation Market?
4. Who are the prominent players in the Plasma Fractionation Market?
5. How is the competition structured in this market?
6. How can I access the full report?

Others Reports:

About Us

MarkNtel Advisors is a globally recognized market research and consulting firm delivering intelligence across the healthcare industry, spanning pharmaceuticals, medical devices, healthcare IT, and biotechnology. Our analysts combine domain expertise with innovation tracking to help healthcare organizations improve efficiency and patient outcomes. Through Consulting Services, we assist clients in interpreting insights, designing go-to-market strategies, and adapting to regulatory changes, fostering sustainable growth in the evolving global healthcare ecosystem.

Reach Us:

MarkNtel Advisors

Sector 63, Noida, Uttar Pradesh-201301, India

Contact No: +91 8719999009

Email: sales@marknteladvisors.com

Website: https://www.marknteladvisors.com

We’re always open to sharing insights, exploring ideas. Follow us to stay updated on the latest news and industry trends.